<

NICOX (EPA:COX) Bausch Health Announces Vyzulta® (latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved in South Korea

Transparency directive : regulatory news

09/02/2021 07:30



Other stories

16/04/2024 01:56
16/04/2024 07:58
15/04/2024 21:24
16/04/2024 04:54
16/04/2024 00:07
16/04/2024 06:39
15/04/2024 23:51
16/04/2024 07:35
15/04/2024 22:07
16/04/2024 07:00
16/04/2024 09:09
16/04/2024 08:22
16/04/2024 07:00
16/04/2024 01:44
16/04/2024 05:55
15/04/2024 14:58
16/04/2024 08:22
15/04/2024 17:01
15/04/2024 16:08
16/04/2024 00:00
16/04/2024 08:46
15/04/2024 15:00
15/04/2024 22:08
16/04/2024 08:41
15/04/2024 15:39
16/04/2024 01:54
16/04/2024 07:48
16/04/2024 08:26
16/04/2024 05:00
15/04/2024 19:00
16/04/2024 09:05
16/04/2024 07:15
15/04/2024 22:37
15/04/2024 16:00
15/04/2024 23:54
16/04/2024 02:53
15/04/2024 16:45
15/04/2024 09:58